ID   PPBT_RAT                Reviewed;         524 AA.
AC   P08289; P14055; P70707;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 2.
DT   24-JUL-2024, entry version 188.
DE   RecName: Full=Alkaline phosphatase, tissue-nonspecific isozyme {ECO:0000303|PubMed:32710882};
DE            Short=AP-TNAP;
DE            Short=TNAP {ECO:0000303|PubMed:32710882};
DE            Short=TNSALP;
DE            EC=3.1.3.1 {ECO:0000305|PubMed:2895632};
DE   AltName: Full=Alkaline phosphatase liver/bone/kidney isozyme;
DE   AltName: Full=Phosphoamidase {ECO:0000305};
DE   AltName: Full=Phosphocreatine phosphatase {ECO:0000250|UniProtKB:P09242};
DE            EC=3.9.1.1 {ECO:0000250|UniProtKB:P09242};
DE   Flags: Precursor;
GN   Name=Alpl;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=3422431; DOI=10.1073/pnas.85.2.319;
RA   Thiede M.A., Yoon K., Golub E.E., Noda M., Rodan G.A.;
RT   "Structure and expression of rat osteosarcoma (ROS 17/2.8) alkaline
RT   phosphatase: product of a single copy gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:319-323(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 355-360 AND 401-404, AND
RP   CATALYTIC ACTIVITY.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=2895632; DOI=10.1042/bj2490661;
RA   Misumi Y., Tashiro K., Hattori M., Sakaki Y., Ikehara Y.;
RT   "Primary structure of rat liver alkaline phosphatase deduced from its
RT   cDNA.";
RL   Biochem. J. 249:661-668(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2544423; DOI=10.1111/j.1432-1033.1989.tb14822.x;
RA   Toh Y., Yamamoto M., Endo H., Misumi Y., Ikehara Y.;
RT   "Isolation and characterization of a rat liver alkaline phosphatase gene. A
RT   single gene with two promoters.";
RL   Eur. J. Biochem. 182:231-237(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 18-47, AND GPI-ANCHOR.
RC   TISSUE=Liver;
RX   PubMed=2834351; DOI=10.1093/oxfordjournals.jbchem.a122211;
RA   Ogata S., Hayashi Y., Yasutake K., Ikehara Y.;
RT   "Chemical identification of lipid components in the membranous form of rat
RT   liver alkaline phosphatase.";
RL   J. Biochem. 102:1609-1615(1987).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=32710882; DOI=10.1016/j.abb.2020.108482;
RA   Favarin B.Z., Bolean M., Ramos A.P., Magrini A., Rosato N., Millan J.L.,
RA   Bottini M., Costa-Filho A.J., Ciancaglini P.;
RT   "Lipid composition modulates ATP hydrolysis and calcium phosphate mineral
RT   propagation by TNAP-harboring proteoliposomes.";
RL   Arch. Biochem. Biophys. 691:108482-108482(2020).
CC   -!- FUNCTION: Alkaline phosphatase that metabolizes various phosphate
CC       compounds and plays a key role in skeletal mineralization and adaptive
CC       thermogenesis. Has broad substrate specificity and can hydrolyze a
CC       considerable variety of compounds: however, only a few substrates, such
CC       as diphosphate (inorganic pyrophosphate; PPi), pyridoxal 5'-phosphate
CC       (PLP) and N-phosphocreatine are natural substrates. Plays an essential
CC       role in skeletal and dental mineralization via its ability to hydrolyze
CC       extracellular diphosphate, a potent mineralization inhibitor, to
CC       phosphate: it thereby promotes hydroxyapatite crystal formation and
CC       increases inorganic phosphate concentration. Acts in a non-redundant
CC       manner with PHOSPHO1 in skeletal mineralization: while PHOSPHO1
CC       mediates the initiation of hydroxyapatite crystallization in the matrix
CC       vesicles (MVs), ALPL/TNAP catalyzes the spread of hydroxyapatite
CC       crystallization in the extracellular matrix. Also promotes
CC       dephosphorylation of osteopontin (SSP1), an inhibitor of hydroxyapatite
CC       crystallization in its phosphorylated state; it is however unclear
CC       whether ALPL/TNAP mediates SSP1 dephosphorylation via a direct or
CC       indirect manner. Catalyzes dephosphorylation of PLP to pyridoxal (PL),
CC       the transportable form of vitamin B6, in order to provide a sufficient
CC       amount of PLP in the brain, an essential cofactor for enzymes
CC       catalyzing the synthesis of diverse neurotransmitters. Additionally,
CC       also able to mediate ATP degradation in a stepwise manner to adenosine,
CC       thereby regulating the availability of ligands for purinergic receptors
CC       (By similarity). Also capable of dephosphorylating microbial products,
CC       such as lipopolysaccharides (LPS) as well as other phosphorylated
CC       small-molecules, such as poly-inosine:cytosine (poly I:C) (By
CC       similarity). Acts as a key regulator of adaptive thermogenesis as part
CC       of the futile creatine cycle: localizes to the mitochondria of
CC       thermogenic fat cells and acts by mediating hydrolysis of N-
CC       phosphocreatine to initiate a futile cycle of creatine
CC       dephosphorylation and phosphorylation. During the futile creatine
CC       cycle, creatine and N-phosphocreatine are in a futile cycle, which
CC       dissipates the high energy charge of N-phosphocreatine as heat without
CC       performing any mechanical or chemical work (By similarity).
CC       {ECO:0000250|UniProtKB:P05186, ECO:0000250|UniProtKB:P09242}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a phosphate monoester + H2O = an alcohol + phosphate;
CC         Xref=Rhea:RHEA:15017, ChEBI:CHEBI:15377, ChEBI:CHEBI:30879,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:67140; EC=3.1.3.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10042,
CC         ECO:0000305|PubMed:2895632};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15018;
CC         Evidence={ECO:0000305|PubMed:2895632};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=diphosphate + H2O = H(+) + 2 phosphate; Xref=Rhea:RHEA:24576,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:43474; Evidence={ECO:0000250|UniProtKB:P09242};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24577;
CC         Evidence={ECO:0000250|UniProtKB:P09242};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + pyridoxal 5'-phosphate = phosphate + pyridoxal;
CC         Xref=Rhea:RHEA:20533, ChEBI:CHEBI:15377, ChEBI:CHEBI:17310,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250|UniProtKB:P05186};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20534;
CC         Evidence={ECO:0000250|UniProtKB:P05186};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + phosphoethanolamine = ethanolamine + phosphate;
CC         Xref=Rhea:RHEA:16089, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57603, ChEBI:CHEBI:58190;
CC         Evidence={ECO:0000250|UniProtKB:P05186};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16090;
CC         Evidence={ECO:0000250|UniProtKB:P05186};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-phosphocreatine = creatine + phosphate;
CC         Xref=Rhea:RHEA:12977, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57947, ChEBI:CHEBI:58092; EC=3.9.1.1;
CC         Evidence={ECO:0000250|UniProtKB:P09242};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12978;
CC         Evidence={ECO:0000250|UniProtKB:P09242};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P09242};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13066;
CC         Evidence={ECO:0000250|UniProtKB:P09242};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ADP + H2O = AMP + H(+) + phosphate; Xref=Rhea:RHEA:61436,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:456215, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P09242};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61437;
CC         Evidence={ECO:0000250|UniProtKB:P09242};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=AMP + H2O = adenosine + phosphate; Xref=Rhea:RHEA:29375,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:16335, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:P09242};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:29376;
CC         Evidence={ECO:0000250|UniProtKB:P09242};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P05187};
CC       Note=Binds 1 Mg(2+) ion. {ECO:0000250|UniProtKB:P05187};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P05187};
CC       Note=Binds 2 Zn(2+) ions. {ECO:0000250|UniProtKB:P05187};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:P05186};
CC   -!- ACTIVITY REGULATION: Phosphatase activity is specifically inhibited by
CC       5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425).
CC       {ECO:0000250|UniProtKB:P09242}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P05186}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P05186};
CC       Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:P05186}. Extracellular
CC       vesicle membrane {ECO:0000269|PubMed:32710882}; Lipid-anchor, GPI-
CC       anchor {ECO:0000250|UniProtKB:P09242}. Mitochondrion membrane
CC       {ECO:0000250|UniProtKB:P09242}; Lipid-anchor, GPI-anchor
CC       {ECO:0000250|UniProtKB:P09242}. Mitochondrion intermembrane space
CC       {ECO:0000250|UniProtKB:P09242}. Note=Localizes to special class of
CC       extracellular vesicles, named matrix vesicles (MVs), which are released
CC       by osteogenic cells (PubMed:32710882). Localizes to the mitochondria of
CC       thermogenic fat cells: tethered to mitochondrial membranes via a GPI-
CC       anchor and probably resides in the mitochondrion intermembrane space
CC       (By similarity). {ECO:0000250|UniProtKB:P09242,
CC       ECO:0000269|PubMed:32710882}.
CC   -!- DOMAIN: Calcium-binding is structural and does not influence the
CC       alkaline phosphatase activity. At very high concentrations, calcium can
CC       however substitute for zinc at zinc-binding sites, leading to strongly
CC       reduced enzyme activity. {ECO:0000250|UniProtKB:P05186}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P05186}.
CC   -!- SIMILARITY: Belongs to the alkaline phosphatase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00714; CAA68703.1; -; mRNA.
DR   EMBL; J03572; AAA41845.1; -; mRNA.
DR   EMBL; X16028; CAA34160.1; -; Genomic_DNA.
DR   EMBL; X16029; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; X16030; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; X16031; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; X16032; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; X16033; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; X16034; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; X16035; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; X16036; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; X16037; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; X16038; CAA34160.1; JOINED; Genomic_DNA.
DR   EMBL; BC088399; AAH88399.1; -; mRNA.
DR   PIR; A28114; A28114.
DR   PIR; S00289; S00289.
DR   RefSeq; NP_037191.1; NM_013059.1.
DR   RefSeq; XP_006239198.1; XM_006239136.3.
DR   RefSeq; XP_017448654.1; XM_017593165.1.
DR   AlphaFoldDB; P08289; -.
DR   SMR; P08289; -.
DR   BioGRID; 247616; 1.
DR   IntAct; P08289; 2.
DR   STRING; 10116.ENSRNOP00000019004; -.
DR   BindingDB; P08289; -.
DR   ChEMBL; CHEMBL2729; -.
DR   GlyConnect; 12; 31 N-Linked glycans.
DR   GlyCosmos; P08289; 5 sites, 56 glycans.
DR   GlyGen; P08289; 6 sites, 56 N-linked glycans (1 site).
DR   iPTMnet; P08289; -.
DR   PhosphoSitePlus; P08289; -.
DR   PaxDb; 10116-ENSRNOP00000019004; -.
DR   Ensembl; ENSRNOT00000019004.6; ENSRNOP00000019004.3; ENSRNOG00000013954.6.
DR   Ensembl; ENSRNOT00055042918; ENSRNOP00055035041; ENSRNOG00055024897.
DR   Ensembl; ENSRNOT00060051094; ENSRNOP00060042506; ENSRNOG00060029423.
DR   Ensembl; ENSRNOT00065042311; ENSRNOP00065034613; ENSRNOG00065024638.
DR   GeneID; 25586; -.
DR   KEGG; rno:25586; -.
DR   UCSC; RGD:2100; rat.
DR   AGR; RGD:2100; -.
DR   CTD; 249; -.
DR   RGD; 2100; Alpl.
DR   eggNOG; KOG4126; Eukaryota.
DR   GeneTree; ENSGT00950000183063; -.
DR   HOGENOM; CLU_008539_4_0_1; -.
DR   InParanoid; P08289; -.
DR   OMA; HEGKANQ; -.
DR   OrthoDB; 35876at2759; -.
DR   PhylomeDB; P08289; -.
DR   TreeFam; TF323513; -.
DR   BRENDA; 3.1.3.1; 5301.
DR   Reactome; R-RNO-163125; Post-translational modification: synthesis of GPI-anchored proteins.
DR   SABIO-RK; P08289; -.
DR   PRO; PR:P08289; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000013954; Expressed in adult mammalian kidney and 19 other cell types or tissues.
DR   ExpressionAtlas; P08289; baseline and differential.
DR   GO; GO:0031012; C:extracellular matrix; ISO:RGD.
DR   GO; GO:0065010; C:extracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; ISS:UniProtKB.
DR   GO; GO:0031966; C:mitochondrial membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098552; C:side of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043262; F:ADP phosphatase activity; IEA:RHEA.
DR   GO; GO:0004035; F:alkaline phosphatase activity; IDA:RGD.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0004427; F:inorganic diphosphate phosphatase activity; IEA:RHEA.
DR   GO; GO:0050187; F:phosphoamidase activity; ISS:UniProtKB.
DR   GO; GO:0052732; F:phosphoethanolamine phosphatase activity; ISO:RGD.
DR   GO; GO:0033883; F:pyridoxal phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0016462; F:pyrophosphatase activity; ISS:UniProtKB.
DR   GO; GO:0030282; P:bone mineralization; ISS:UniProtKB.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0019725; P:cellular homeostasis; ISO:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; ISO:RGD.
DR   GO; GO:0071529; P:cementum mineralization; IEP:RGD.
DR   GO; GO:0003006; P:developmental process involved in reproduction; ISO:RGD.
DR   GO; GO:0001958; P:endochondral ossification; ISO:RGD.
DR   GO; GO:0140651; P:futile creatine cycle; ISO:RGD.
DR   GO; GO:0140928; P:inhibition of non-skeletal tissue mineralization; ISO:RGD.
DR   GO; GO:0055062; P:phosphate ion homeostasis; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:UniProtKB.
DR   GO; GO:0042822; P:pyridoxal phosphate metabolic process; ISO:RGD.
DR   GO; GO:0046677; P:response to antibiotic; ISO:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IDA:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0036005; P:response to macrophage colony-stimulating factor; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:1904383; P:response to sodium phosphate; ISO:RGD.
DR   GO; GO:0034516; P:response to vitamin B6; ISO:RGD.
DR   GO; GO:0033280; P:response to vitamin D; ISO:RGD.
DR   CDD; cd16012; ALP; 1.
DR   Gene3D; 3.40.720.10; Alkaline Phosphatase, subunit A; 1.
DR   InterPro; IPR001952; Alkaline_phosphatase.
DR   InterPro; IPR018299; Alkaline_phosphatase_AS.
DR   InterPro; IPR017850; Alkaline_phosphatase_core_sf.
DR   PANTHER; PTHR11596; ALKALINE PHOSPHATASE; 1.
DR   PANTHER; PTHR11596:SF74; ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC ISOZYME; 1.
DR   Pfam; PF00245; Alk_phosphatase; 1.
DR   PRINTS; PR00113; ALKPHPHTASE.
DR   SMART; SM00098; alkPPc; 1.
DR   SUPFAM; SSF53649; Alkaline phosphatase-like; 1.
DR   PROSITE; PS00123; ALKALINE_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   Biomineralization; Calcium; Cell membrane; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; GPI-anchor; Hydrolase; Lipoprotein;
KW   Magnesium; Membrane; Metal-binding; Mitochondrion; Phosphoprotein;
KW   Reference proteome; Signal; Zinc.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000269|PubMed:2834351"
FT   CHAIN           18..501
FT                   /note="Alkaline phosphatase, tissue-nonspecific isozyme"
FT                   /id="PRO_0000024027"
FT   PROPEP          502..524
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000024028"
FT   ACT_SITE        110
FT                   /note="Phosphoserine intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:P05187,
FT                   ECO:0000255|PROSITE-ProRule:PRU10042"
FT   BINDING         60
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   BINDING         60
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   BINDING         110
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   BINDING         173
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   BINDING         235
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P05186"
FT   BINDING         290
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P05186"
FT   BINDING         291
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P05186"
FT   BINDING         306
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P05186"
FT   BINDING         332
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   BINDING         337
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   BINDING         341
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   BINDING         378
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   BINDING         379
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   BINDING         454
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   MOD_RES         110
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   LIPID           501
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        230
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        271
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        303
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        430
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        139..201
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   DISULFID        489..497
FT                   /evidence="ECO:0000250|UniProtKB:P05187"
FT   CONFLICT        12
FT                   /note="T -> P (in Ref. 1; AAA41845)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        116
FT                   /note="A -> Y (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        193
FT                   /note="P -> R (in Ref. 1; AAA41845)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        234
FT                   /note="V -> E (in Ref. 2; CAA68703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        254
FT                   /note="S -> T (in Ref. 2; CAA68703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        331
FT                   /note="V -> E (in Ref. 2; CAA68703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        374
FT                   /note="V -> L (in Ref. 2; CAA68703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        380..388
FT                   /note="SHVFTFGGY -> HPTFSRLVA (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        391
FT                   /note="R -> Q (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        463
FT                   /note="A -> C (in Ref. 2; CAA68703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        474
FT                   /note="V -> I (in Ref. 2; CAA68703)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   524 AA;  57659 MW;  BD75A4B87117DF03 CRC64;
     MILPFLVLAI GTCLTNSFVP EKEKDPSYWR QQAQETLKNA LKLQKLNTNV AKNIIMFLGD
     GMGVSTVTAA RILKGQLHHN TGEETRLEMD KFPFVALSKT YNTNAQVPDS AGTATAYLCG
     VKANEGTVGV SAATERTRCN TTQGNEVTSI LRWAKDAGKS VGIVTTTRVN HATPSAAYAH
     SADRDWYSDN EMPPEALSQG CKDIAYQLMH NIKDIDVIMG GGRKYMYPKN RTDVEYELDE
     KARGTRLDGL DLISIWKSFK PRHKHSHYVW NRTELLALDP SRVDYLLGLF EPGDMQYELN
     RNNLTDPSLS EMVEVALRIL TKNPKGFFLL VEGGRIDHGH HEGKAKQALH EAVEMDEAIG
     KAGTMTSQKD TLTVVTADHS HVFTFGGYTP RGNSIFGLAP MVSDTDKKPF TAILYGNGPG
     YKVVDGEREN VSMVDYAHNN YQAQSAVPLR HETHGGEDVA VFAKGPMAHL LHGVHEQNYI
     PHVMAYASCI GANLDHCAWA SSASSPSPGA LLLPLALFPL RTLF
//
